Medicines

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade

GORD quality standards

NICE has published nine quality standards covering GORD in children and young people

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)

Dispensary: Reltebon price cut

Actavis has reduced the list price of Reltebon (oxycodone hydrochloride) prolonged-release tablets

Entresto: a new heart failure drug

Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure.

Dulaglutide gets green light in Scotland

The Scottish Medicines Consortium has accepted Trulicity (dulaglutide) for use in NHS Scotland.  
Previous 1 2 3 Next

Latest

Improving the safety of home medication deliveries

A discussion paper has been published on improving home medication delivery services for vulnerable patients

GPhC issues new guidance on religion, values and beliefs

The GPhC has published guidance for when religion, personal values or beliefs might impact on professional practice

Views

Sector losing policy battle as CPhO faces mounting criticism

By Richard Thomas, editor, Pharmacy Magazine. If there were any small doubts remaining about what the high-ups in Govern...

Popular

Headache & migraine: Knock it on the head

Migraine can blight the lives of those affected but there is plenty pharmacists can do to lessen its impact on patients

Charities call on government to do more for carers

With a survey suggesting that the work of the UK's 6.5million unpaid carers is not valued enough, charities are calling ...

Voltarol Emulgel: larger tube for OA sufferers

GSK is launching a 180g tube of Voltarol Emulgel P to help people with the pain associated with osteoarthritis